BRIEF published on 04/16/2025 at 07:05, 9 months 21 days ago Innate Pharma General Meeting Announced for May 22, 2025 Shareholders Biotechnology General Meeting Innate Pharma Marseille
PRESS RELEASE published on 04/16/2025 at 07:00, 9 months 21 days ago Informations privilégiées / Autres communiqués L'assemblée générale annuelle d'Innate Pharma aura lieu le 22 mai 2025 à Marseille. Informations disponibles pour les actionnaires en ligne ou sur demande. Détails sur les traitements contre le cancer Biotechnologie Assemblée Générale Traitement Cancer Innate Pharma
BRIEF published on 04/03/2025 at 13:24, 10 months 4 days ago Innate Pharma participe au Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Immunothérapie Oncologie Innate Pharma Forum Virtuel
BRIEF published on 04/03/2025 at 13:24, 10 months 4 days ago Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Oncology Immunotherapy Innate Pharma Virtual Forum
PRESS RELEASE published on 04/03/2025 at 13:19, 10 months 4 days ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Innate Pharma annonce sa participation au Stifel 2025 Virtual Targeted Oncology Forum. Présentation prévue le 9 avril 2025. Informations sur les traitements innovants contre le cancer Immunothérapie Cancer Oncologie Innate Pharma Stifel 2025
BRIEF published on 04/03/2025 at 13:18, 10 months 4 days ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
BRIEF published on 04/03/2025 at 13:18, 10 months 4 days ago Innate Pharma participera au forum virtuel d'oncologie Stifel 2025 Biotechnologie Immunothérapie Événement Virtuel Innate Pharma Forum D'oncologie 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 10 months 4 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 10 months 10 days ago Annual financial and audit reports / Annual financial report
PRESS RELEASE published on 03/28/2025 at 14:32, 10 months 10 days ago Rapports financiers et d'audit annuels / Rapport financier annuel
Published on 02/07/2026 at 01:00, 22 hours 14 minutes ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 1 hour ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 7 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 9 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 2 hours 14 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 6 hours 39 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 6 hours 54 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 3 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 5 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 4 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 4 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 7 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 7 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 15 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
